CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 4 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $783,008 | -47.1% | 66,981 | -39.2% | 0.01% | -50.0% |
| Q2 2023 | $1,481,222 | -11.9% | 110,210 | +8.7% | 0.01% | -14.3% |
| Q1 2023 | $1,680,831 | +88086.3% | 101,377 | -1.1% | 0.01% | -12.5% |
| Q4 2022 | $1,906 | -99.8% | 102,469 | +18.9% | 0.02% | +45.5% |
| Q3 2022 | $1,106,000 | – | 86,187 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 159,791 | $1,868 | 5.34% |
| Opaleye Management Inc. | 1,205,000 | $14,086,450 | 4.58% |
| GABLES CAPITAL MANAGEMENT INC. | 431,955 | $5,049,554 | 3.51% |
| JW Asset Management, LLC | 563,392 | $6,586,052 | 2.85% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 8,192,000 | $95,764,480 | 2.11% |
| Seaport Global Advisors, LLC | 45,941 | $537,050 | 1.61% |
| Capital Impact Advisors, LLC | 67,067 | $784,013 | 1.31% |
| Ikarian Capital, LLC | 505,862 | $5,913,527 | 0.71% |
| MOODY ALDRICH PARTNERS LLC | 273,512 | $3,197,355 | 0.61% |
| Paradiem, LLC | 166,905 | $1,951,119 | 0.59% |